Metformin synergistic pemetrexed suppresses non‐small‐cell lung cancer cell proliferation and invasion in vitro

The aim of this study was to investigate whether metformin in combination with pemetrexed has an effect on the treatment of non‐small‐cell lung cancer (NSCLC) models and to explore the related molecular mechanism. The half maximal inhibitory concentration (IC50) and combination index (CI) of metform...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Feng, Xiuli, Li, Tao, Yi, Erpan, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548881/
https://www.ncbi.nlm.nih.gov/pubmed/28719077
http://dx.doi.org/10.1002/cam4.1133

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548881/
https://www.ncbi.nlm.nih.gov/pubmed/28719077
http://dx.doi.org/10.1002/cam4.1133

Ejemplares similares